SiSaf Ltd
PrivateLast Round
Series B
Nov 26, 2020
Total Funding Raised
$43.47M
Company Overview
SiSaf Ltd is a biopharmaceutical company that develops RNA therapeutics for conditions such as cancer and rare genetic skeletal disorders using its proprietary Bio-Courier® delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SiSaf Ltd Comparables
Compare SiSaf Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevant Sciences | 82% | |
| ReCode Therapeutics | 78% | |
| Acuitas Therapeutics | 78% | |
SiSaf Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 26, 2020 | ||||
| Series A Extension | Aug 1, 2018 | ||||
| Series A | Sep 19, 2016 | ||||
| Seed | Oct 23, 2013 | ||||
| Seed | Apr 4, 2011 |
Key People
Founding team and executive leadership
SiSaf Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Ulster Limited | Seed, Series A Extension |
| Future Fund | Series B |
| Invest Northern Ireland | Series A Extension, Seed, Series A |
| Silicon Valley Global Ventures | Seed |
| Clarendon Fund Managers | Seed |
| Vickers Venture Partners | Series A Extension, Series B, Series A |
| Innovation Ulster Ltd | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2020
$13M round led by Vickers Venture Partners.
- Sep 19, 2016
$4M round led by Vickers Venture Partners.
SiSaf Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SiSaf Ltd's valuation, stock price, and market status.